[Pharmacologico-clinical trials of the association of L-dopa and gamma-hydroxybutyric acid in therapy of Parkinson's disease].
D000818:Animals; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D006801:Humans; D006885:Hydroxybutyrates / Q000627:therapeutic use*; D051379:Mice; D010300:Parkinson Disease / Q000188:drug therapy*
D006885:Hydroxybutyrates; D004295:Dihydroxyphenylalanine
Sperimentazione farmacologico-clinica dell'associazione di L-dopa e acido gamma-idrossi-butirrico nella terapia del morbo di Parkinson.